{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:25:14Z","timestamp":1790616314497,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Erasmus University Rotterdam Fellowship","award":["CvB\/HP\/PR\/UB00003201"],"award-info":[{"award-number":["CvB\/HP\/PR\/UB00003201"]}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["NOVEL Transcan 2"],"award-info":[{"award-number":["NOVEL Transcan 2"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sustained B-cell activation is an important mechanism contributing to B-cell lymphoma (BCL). We aimed to validate four previously reported B-cell activation markers predictive of BCL risk (sCD23, sCD27, sCD30, and CXCL13) and to examine their possible mediating effects on the association between anthropometric and lifestyle factors and major BCL subtypes. Pre-diagnostic serum levels were measured for 517 BCL cases and 525 controls in a nested case\u2013control study. The odds ratios of BCL were 6.2 in the highest versus lowest quartile for sCD23, 2.6 for sCD30, 4.2 for sCD27, and 2.6 for CXCL13. Higher levels of all markers were associated with increased risk of chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL). Following mutual adjustment for the other immune markers, sCD23 remained associated with all subtypes and CXCL13 with FL and DLBCL. The associations of sCD23 with CLL and DLBCL and CXCL13 with DLBCL persisted among cases sampled\u2009&gt;\u20099\u00a0years before diagnosis. sCD23 showed a good predictive ability (area under the curve\u2009=\u20090.80) for CLL, in particular among older, male participants. sCD23 and CXCL13 showed a mediating effect between body mass index (positive) and DLBCL risk, while CXCL13 contributed to the association between physical activity (inverse) and DLBCL. Our data suggest a role of B-cell activation in BCL development and a mediating role of the immune system for lifestyle factors.<\/jats:p>","DOI":"10.1038\/s41598-020-70790-9","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T12:27:09Z","timestamp":1597408029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development"],"prefix":"10.1038","volume":"10","author":[{"given":"Fatemeh","family":"Saberi Hosnijeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter M.","family":"Kolijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Casabonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Nieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Solans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Naudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Mckay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete","family":"Weiderpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Perduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Ricceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafina","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Trichopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Karakatsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Canzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagfinn","family":"Aune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Boeing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias B.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Perez-Cornago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton W.","family":"Langerak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"70790_CR1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/COH.0b013e32833f327e","volume":"5","author":"RF Ambinder","year":"2010","unstructured":"Ambinder, R. F., Bhatia, K., Martinez-Maza, O. & Mitsuyasu, R. Cancer biomarkers in HIV patients. Curr. Opin. HIV AIDS 5, 531\u2013537 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"70790_CR2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","volume":"20","author":"EC Breen","year":"2011","unstructured":"Breen, E. C. et al. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS\u2013associated non-hodgkin B-Cell lymphoma. Cancer Epidemiol. Biomark. Prev. 20, 1303\u20131314 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000093022","volume":"27","author":"EC Breen","year":"2006","unstructured":"Breen, E. C. et al. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin\u2019s B cell lymphoma. Tumour Biol. 27, 187\u2013194 (2006).","journal-title":"Tumour Biol."},{"key":"70790_CR4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/clim.1999.4782","volume":"93","author":"D Widney","year":"1999","unstructured":"Widney, D. et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin. Immunol. 93, 114\u2013123 (1999).","journal-title":"Clin. Immunol."},{"key":"70790_CR5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jir.2005.25.702","volume":"25","author":"DP Widney","year":"2005","unstructured":"Widney, D. P. et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J. Interferon Cytokine Res. 25, 702\u2013706 (2005).","journal-title":"J. Interferon Cytokine Res."},{"key":"70790_CR6","first-page":"164586","volume":"2010","author":"DP Widney","year":"2010","unstructured":"Widney, D. P. et al. Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin\u2019s lymphoma. AIDS Res. Treat. 2010, 164586 (2010).","journal-title":"AIDS Res. Treat."},{"key":"70790_CR7","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.aids.0000184924.04983.7c","volume":"19","author":"EC Breen","year":"2005","unstructured":"Breen, E. C. et al. Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin\u2019s B-cell lymphoma. AIDS 19, 1711\u20131712 (2005).","journal-title":"AIDS"},{"key":"70790_CR8","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1158\/0008-5472.CAN-12-1639","volume":"72","author":"AJ De Roos","year":"2012","unstructured":"De Roos, A. J. et al. Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma. Cancer Res. 72, 4733\u20134743 (2012).","journal-title":"Cancer Res."},{"key":"70790_CR9","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-11-0165","volume":"71","author":"MP Purdue","year":"2011","unstructured":"Purdue, M. P. et al. Prediagnostic serum levels of cytokines and other immune markers and risk of non-Hodgkin lymphoma. Cancer Res. 71, 4898\u20134907 (2011).","journal-title":"Cancer Res."},{"key":"70790_CR10","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood-2009-04-217521","volume":"114","author":"MP Purdue","year":"2009","unstructured":"Purdue, M. P. et al. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood 114, 2730\u20132732 (2009).","journal-title":"Blood"},{"key":"70790_CR11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1055-9965.EPI-11-0396","volume":"20","author":"R Vermeulen","year":"2011","unstructured":"Vermeulen, R. et al. Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population. Cancer Epidemiol. Biomark. Prev. 20, 1925\u20131927 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR12","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/ijc.29969","volume":"138","author":"FS Hosnijeh","year":"2016","unstructured":"Hosnijeh, F. S. et al. Soluble B-cell activation markers sCD27 and sCD30 and future risk of B-cell Lymphomas and multiple myeloma: a nested case-control study and meta-analyses. Int. J. Cancer 138, 2357\u20132367 (2016).","journal-title":"Int. J. Cancer"},{"key":"70790_CR13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","volume":"48","author":"LM Morton","year":"2014","unstructured":"Morton, L. M. et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-Hodgkin lymphoma subtypes project. J. Natl. Cancer Inst. Monogr. 48, 130\u2013144 (2014).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"70790_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ijc.32109","volume":"145","author":"T Psaltopoulou","year":"2019","unstructured":"Psaltopoulou, T. et al. Anthropometric characteristics, physical activity and risk of hematological malignancies: a systematic review and meta-analysis of cohort studies. Int. J. Cancer 145, 347\u2013359 (2019).","journal-title":"Int. J. Cancer"},{"key":"70790_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/01652176.2012.709362","volume":"32","author":"FS Hosnijeh","year":"2012","unstructured":"Hosnijeh, F. S., Heederik, D. & Vermeulen, R. A review of the role of lymphoma markers and occupational and environmental exposures. Vet. Q. 32, 61\u201373 (2012).","journal-title":"Vet. Q."},{"key":"70790_CR16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1158\/1055-9965.EPI-06-1081","volume":"16","author":"CF Skibola","year":"2007","unstructured":"Skibola, C. F. Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomark. Prev. 16, 392\u2013395 (2007).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR17","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1073\/pnas.1004185107","volume":"107","author":"QL Lam","year":"2010","unstructured":"Lam, Q. L., Wang, S., Ko, O. K., Kincade, P. W. & Lu, L. Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1. Proc. Natl. Acad. Sci. U. S. A. 107, 13812\u201313817 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"70790_CR18","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/10428190290033288","volume":"43","author":"C Schneider","year":"2002","unstructured":"Schneider, C. & H\u00fcbinger, G. Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor family. Leuk. Lymphoma 43, 1355\u20131366 (2002).","journal-title":"Leuk. Lymphoma"},{"key":"70790_CR19","first-page":"1248","volume":"129","author":"F Monsalve","year":"2001","unstructured":"Monsalve, F., Romero-A, T., Estevez, J., Costa, L. & Callejas, D. Serum levels of soluble CD30 molecule in hepatitis B virus infection. Rev. Med Chile 129, 1248\u20131252 (2001).","journal-title":"Rev. Med Chile"},{"key":"70790_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2249.1996.915607.x","volume":"103","author":"G Fattovich","year":"1996","unstructured":"Fattovich, G. et al. Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin. Exp. Immunol. 103, 105\u2013110 (1996).","journal-title":"Clin. Exp. Immunol."},{"key":"70790_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/clin.1997.4371","volume":"84","author":"AS Bansal","year":"1997","unstructured":"Bansal, A. S., Bruce, J., Hogan, P. G., Prichard, P. & Powell, E. E. Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection. Clin. Immunol. Immunopathol. 84, 139\u2013144 (1997).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"70790_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/clin.1994.1048","volume":"71","author":"M Al-Janadi","year":"1994","unstructured":"Al-Janadi, M., Al-Wabel, A. & Raziuddin, S. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 71, 33\u201337 (1994).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"70790_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.autrev.2013.11.001","volume":"13","author":"B Terrier","year":"2014","unstructured":"Terrier, B. et al. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection. Autoimmun. Rev. 13, 319\u2013326 (2014).","journal-title":"Autoimmun. Rev."},{"key":"70790_CR24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/carcin\/bgq121","volume":"31","author":"Q Lan","year":"2010","unstructured":"Lan, Q. et al. Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers. Carcinogenesis 31, 1592\u20131596 (2010).","journal-title":"Carcinogenesis"},{"key":"70790_CR25","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/1055-9965.EPI-13-0651","volume":"22","author":"FS Hosnijeh","year":"2013","unstructured":"Hosnijeh, F. S., Portengen, L., Bueno-de-Mesquita, H. B., Heederik, D. & Vermeulen, R. Circulating soluble CD27 and CD30 in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Epidemiol. Biomark. Prev. 22, 2420\u20132424 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR26","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2147\/OTT.S129781","volume":"10","author":"D Chen","year":"2017","unstructured":"Chen, D., Zhang, F., Ren, H., Luo, J. & Wang, S. Role of cytokines and chemokines in alcohol-induced tumor promotion. Onco Targets Ther. 10, 1665\u20131671 (2017).","journal-title":"Onco Targets Ther."},{"key":"70790_CR27","first-page":"185","volume":"37","author":"S Pasala","year":"2015","unstructured":"Pasala, S., Barr, T. & Messaoudi, I. Impact of alcohol abuse on the adaptive immune system. Alcohol Res. 37, 185\u2013197 (2015).","journal-title":"Alcohol Res."},{"key":"70790_CR28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/1055-9965.EPI-14-1107","volume":"24","author":"R Kaaks","year":"2015","unstructured":"Kaaks, R. et al. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23. Cancer Epidemiol. Biomark. Prev. 24, 538\u2013545 (2015).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR29","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-16-2345","volume":"77","author":"F Sp\u00e4th","year":"2017","unstructured":"Sp\u00e4th, F. et al. Biomarker dynamics in B-cell lymphoma: a longitudinal prospective study of plasma samples up to 25 years before diagnosis. Cancer Res. 77, 1408\u20131415 (2017).","journal-title":"Cancer Res."},{"key":"70790_CR30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00277-018-3356-z","volume":"97","author":"EP Allain","year":"2018","unstructured":"Allain, E. P. et al. Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients. Ann. Hematol. 97, 1649\u20131661 (2018).","journal-title":"Ann. Hematol."},{"key":"70790_CR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2010.04210.x","volume":"162","author":"M Acharya","year":"2010","unstructured":"Acharya, M. et al. CD23\/Fc\u03b5RII: molecular multi-tasking. Clin. Exp. Immunol. 162, 12\u201323 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"70790_CR32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3324\/haematol.2017.183236","volume":"103","author":"MM Epstein","year":"2018","unstructured":"Epstein, M. M. et al. Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies. Haematologica 103, 1679\u20131687 (2018).","journal-title":"Haematologica"},{"key":"70790_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/cei.12444","volume":"179","author":"SR Shaikh","year":"2014","unstructured":"Shaikh, S. R., Haas, K. M., Beck, M. A. & Teague, H. The effects of diet-induced obesity on B cell function. Clin. Exp. Immunol. 179, 90\u201399 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"70790_CR34","doi-asserted-by":"crossref","first-page":"51335138","DOI":"10.1073\/pnas.1215840110","volume":"110","author":"J DeFuria","year":"2013","unstructured":"DeFuria, J. et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. U. S. A. 110, 51335138 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"70790_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1467-789x.2001.00025.x","volume":"2","author":"A Marti","year":"2001","unstructured":"Marti, A., Marcos, A. & Martinez, J. A. Obesity and immune function relationships. Obes. Rev. 2, 131\u2013140 (2001).","journal-title":"Obes. Rev."},{"key":"70790_CR36","first-page":"353","volume":"20","author":"DC Nieman","year":"1996","unstructured":"Nieman, D. C. et al. Immune response to obesity and moderate weight loss. Int. J. Obes. Relat. Metab. Disord. 20, 353\u2013360 (1996).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"70790_CR37","first-page":"6","volume":"17","author":"NP Walsh","year":"2011","unstructured":"Walsh, N. P. et al. Position statement. Part one: immune function and exercise. Exerc. Immunol. Rev. 17, 6\u201363 (2011).","journal-title":"Exerc. Immunol. Rev."},{"key":"70790_CR38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/1055-9965.EPI-13-0182","volume":"22","author":"NV Vermaete","year":"2013","unstructured":"Vermaete, N. V. et al. Physical activity and risk of lymphoma: a meta-analysis. Cancer Epidemiol. Biomark. Prev. 22, 1173\u20131184 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.31330","volume":"143","author":"T Psaltopoulou","year":"2018","unstructured":"Psaltopoulou, T. et al. Alcohol consumption and risk of hematological malignancies: a meta-analysis of prospective studies. Int. J. Cancer 143, 486\u2013495 (2018).","journal-title":"Int. J. Cancer"},{"key":"70790_CR40","unstructured":"Jerolon, A., Baglietto, L., Birmele, E., Perduca, V. & Alarcon, F. Causal mediation analysis in presence of multiple mediators uncausally related. arXiv:1809.08018v2 [stat.ME] (2018)."},{"key":"70790_CR41","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1055-9965.EPI-09-1237","volume":"19","author":"FS Hosnijeh","year":"2010","unstructured":"Hosnijeh, F. S. et al. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomark. Prev. 19, 1577\u20131584 (2010).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70790_CR42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli, E. et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 5, 1113\u20131124 (2002).","journal-title":"Public Health Nutr."},{"issue":"Suppl 1","key":"70790_CR43","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","volume":"26","author":"E Riboli","year":"1997","unstructured":"Riboli, E. & Kaaks, R. The EPIC Project: rationale and study design. European prospective investigation into cancer and nutrition. Int. J. Epidemiol. 26(Suppl 1), S6\u2013S14 (1997).","journal-title":"Int. J. Epidemiol."},{"key":"70790_CR44","volume-title":"International classification of diseases for oncology (ICD-O)","year":"2000","unstructured":"Fritz, A. et al. (eds) International classification of diseases for oncology (ICD-O) 3rd edn. (World Health Organization, Geneva, 2000).","edition":"3"},{"key":"70790_CR45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1289\/ehp.7199","volume":"112","author":"JH Lubin","year":"2004","unstructured":"Lubin, J. H. et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ. Health Prospect. 112, 1691\u20131696 (2004).","journal-title":"Environ. Health Prospect."},{"key":"70790_CR46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1079\/PHN2002439","volume":"6","author":"NJ Wareham","year":"2003","unstructured":"Wareham, N. J. et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 6, 407\u2013413 (2003).","journal-title":"Public Health Nutr."},{"key":"70790_CR47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/crad.1999.0444","volume":"55","author":"PM Maceneaney","year":"2000","unstructured":"Maceneaney, P. M. & Malone, D. E. The meaning of diagnostic test results: a spreadsheet for swift data analysis. Clin. Radiol. 55, 227\u2013235 (2000).","journal-title":"Clin. Radiol."},{"key":"70790_CR48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/a0020761","volume":"15","author":"K Imai","year":"2010","unstructured":"Imai, K., Keele, L. & Tingley, D. A general approach to causal mediation analysis. Psychol. Methods 15, 309\u2013334 (2010).","journal-title":"Psychol. Methods"},{"key":"70790_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v059.i05","volume":"59","author":"D Tingley","year":"2014","unstructured":"Tingley, D., Yamamoto, T., Hirose, K., Keele, L. & Imai, K. Mediation: R Package for causal mediation analysis. J. Stat. Softw. 59, 1\u201338 (2014).","journal-title":"J. Stat. Softw."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70790-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:16:26Z","timestamp":1670346986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70790-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70790"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70790-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"12 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13814"}}